Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orthopedic Implant Classification Scheme Proposed To HHS Secretary’s Panel

This article was originally published in The Gray Sheet

Executive Summary

FDA's medical device classification system should include a separate category for non-life-threatening implants such as prostheses, according to the American Academy of Orthopaedic Surgeons

You may also be interested in...

Shoulder, knee implant reclassification petitions being crafted by orthopedic coalition.

KNEE, SHOULDER IMPLANT DOWNCLASSIFICATION PETITIONS are under development by a coalition of orthopedics groups including the American Academy of Orthopedic Surgeons, the American Orthopedic Association, the American Society for Testing and Materials, the Orthopedic Surgical Manufacturers Association and the Orthopedic Research Society. Informally known as the "Device Forum," the group hopes to present preliminary drafts of the petitions -- which will seek to move certain knee and shoulder implants from Class III to Class II -- to the FDA Office of Device Evaluation's Orthopedic Devices Branch at the end of April.

Recent eMDR Change By FDA Asks Adverse Event Reporters About Third-Party Servicers

The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.

Experts: HHS Review Proposal May Free Industry From Regulatory Red Tape

Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts